Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Taysha Gene Therapies Inc (NQ: TSHA )

3.776 -0.144 (-3.66%)
Streaming Delayed Price Updated: 2:53 PM EDT, Jun 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 585,869
Open 3.890
Bid (Size) 3.770 (12)
Ask (Size) 3.780 (6)
Prev. Close 3.920
Today's Range 3.740 - 3.930
52wk Range 0.5000 - 4.020
Shares Outstanding 64,465,037
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Breaking Down Taysha Gene Therapies: 16 Analysts Share Their Views
Via Benzinga
TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q1 2024
TSHA stock results show that Taysha Gene Therapies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+120.84%
+120.84%
1 Month
+57.35%
+57.35%
3 Month
+61.38%
+61.38%
6 Month
+126.13%
+126.13%
1 Year
+393.65%
+393.65%

More News

Read More
11 Analysts Assess Taysha Gene Therapies: What You Need To Know
Via Benzinga
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Evaluating Taysha Gene Therapies: Insights From 7 Financial Analysts
Via Benzinga
Taysha Gene Therapies: Q4 Earnings Insights
Via Benzinga
Taysha Gene Therapies Earnings Preview
Via Benzinga
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Spinal Delivery Of Taysha's Gene Therapy Shows Promise In Rare Childhood Neurodegenerative Disease
Via Benzinga
Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Taysha Gene Therapies Shares Jump On Initial Data From First Pediatric Patient With Rare Neurodevelopmental Disorder
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Taysha Gene Therapies Stock Soars On FY23 Results: Here's Why
Via Benzinga
Earnings Scheduled For March 19, 2024
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
7 Micro-Cap Stocks That Could Majorly Surprise Investors
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.